These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1359528)

  • 21. Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Nephron; 1990; 56(2):179-85. PubMed ID: 1978736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diuretic and natriuretic properties of fenoldopam in chronic renal failure.
    Andrés A; García-Robles R; Alcázar JM; Alvarez C; Martínez J; Oliet A; Sancho J; Rodicio JL; Ruilope LM
    J Hypertens Suppl; 1989 Dec; 7(6):S326-7. PubMed ID: 2576671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human vasodilator responses to a dopamine agonist: possible mechanisms.
    Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
    J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous fenoldopam infusion in severe heart failure.
    Patel JJ; Mitha AS; Sareli P; de Vaal JB
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lithium and the renal response to gludopa, fenoldopam and dopamine.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Oct; 30(4):652-3. PubMed ID: 1981323
    [No Abstract]   [Full Text] [Related]  

  • 26. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
    Horn PT; Kohli JD
    Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure.
    van Veldhuisen DJ; Girbes AR; de Graeff PA; Lie KI
    Int J Cardiol; 1992 Dec; 37(3):293-300. PubMed ID: 1361484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal dopamine and tubular DA-1 receptors in the regulation of sodium excretion.
    Lokhandwala MF; Vyas SJ; Hegde SS
    J Auton Pharmacol; 1990; 10 Suppl 1():s31-9. PubMed ID: 1983007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX; Gellai M; Brooks DP
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium and the natriuretic response to gludopa, fenoldopam and dopamine.
    Schoors DF; Dupont AG
    Br J Clin Pharmacol; 1990 Oct; 30(4):651-2. PubMed ID: 1981322
    [No Abstract]   [Full Text] [Related]  

  • 33. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
    Zhao RR; Wang PH; Zhang WF; Fennell WH
    Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
    López-Sendón J
    Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
    Marchetti GV
    Cardiology; 1990; 77 Suppl 5():22-9. PubMed ID: 1980631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine stimulation of cAMP production in cultured opossum kidney cells.
    Cheng L; Precht P; Frank D; Liang CT
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F877-82. PubMed ID: 1691897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
    Polak MJ; Taylor DA
    Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.